Skip to main content
Caplight Logo









Respiro Diagnostics

Respiro Diagnostics

Private
LeedsHealthcare & Life Scienceshttps://respirodiagnostics.com/

Last Round

Pre Seed

Jul 8, 2026

Total Funding Raised

$1.34M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Respiro Diagnostics is a biotechnology company that develops a breath-based diagnostic platform for the non-invasive detection and molecular profiling of lung cancer and other respiratory diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

liquid biopsybreath biopsymolecular diagnosticslung cancer screeningnon-invasive diagnosticsbreath analysisbiomarker discoveryprecision medicinerespiratory diseasediagnostic devicemulti-omicsearly cancer detectionclinical researchmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Respiro Diagnostics Comparables

Compare Respiro Diagnostics with similar companies based on industry and business-model similarity.

Respiro Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vocxi Health
82%
Bioxhale Ltd
81%
Menssana Research Inc.
78%

Respiro Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedJul 8, 2026

Respiro Diagnostics Investors

Notable investors and investment history

Respiro Diagnostics investors
InvestorRounds
Amadeus Capital PartnersPre Seed
ZincPre Seed
Innovate UKPre Seed
The Francis Crick InstitutePre Seed
SFC CapitalPre Seed
ConceptionXPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 8, 2026

    $1.34M round led by SFC Capital and Zinc

Respiro Diagnostics Filings

Explore SEC and related filing metadata, where available.

Respiro Diagnostics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Respiro Diagnostics's valuation, stock price, and market status.

Is Respiro Diagnostics a public or private company?

Respiro Diagnostics is a private company.

What is the current stock price of Respiro Diagnostics?

Respiro Diagnostics is a private company with no public stock price. Caplight tracks Respiro Diagnostics's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Respiro Diagnostics worth (valuation)?

Valuation information for Respiro Diagnostics is not publicly available.

Can I buy Respiro Diagnostics stock?

Respiro Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Respiro Diagnostics's last funding round?

Respiro Diagnostics's most recent funding round was Pre Seed on July 8, 2026.

Who are the main investors in Respiro Diagnostics?

Key investors in Respiro Diagnostics include Zinc, SFC Capital.

Will Respiro Diagnostics IPO soon?

No public IPO plans have been announced for Respiro Diagnostics.

How can I track Respiro Diagnostics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Respiro Diagnostics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLeeds
Employee Range3
Year Founded2025
Last FundingJul 8, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?